輔助人工心臟市場規模、佔有率、成長分析：按產品類型、按流量類型、按地區 - 產業預測，2024-2031年

2022年輔助人工心臟的全球市場規模為22億美元，從2023年的24億美元成長到2031年的59億美元，預計預測期內（2024-2031年）年複合成長率為7.9。

心血管疾病的快速增加和心臟移植需求的成長將在未來幾年顯著推動輔助人工心臟（VAD）的銷售。世界人口迅速老化將進一步推動對這種救生設備的需求。新型輔助人工心臟的設計和功能創新，以及研發投資的增加，預計將為該領域的公司創造新的商機。此外，全球醫療保健支出的成長可能會提高輔助人工心臟製造商的盈利。全人工心臟的接受度和可用性的提高也可能支持預測期內及以後的市場擴張。然而，輔助人工心臟的高成本、與其使用相關的潛在併發症以及嚴格的監管環境等挑戰可能會抑制長期的需求前景。總體而言，市場看到了由人口趨勢和技術進步推動的強勁成長機會，但相關人員必須克服財務和監管障礙才能充分利用這些機會。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二級資料和一級資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制因素和挑戰
• 波特分析及影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 案例研究分析
• PESTEL分析
• 總體經濟指標
• 貿易分析
• Start-Ups分析
• 原料分析
• 供應鏈分析
• 價格分析

輔助人工心臟市場：依產品

• 左心室輔助裝置
• 右心室輔助裝置
• 雙心室輔助裝置
• 全人工心臟

輔助人工心臟市場：依流程類型

• 脈動流
• 連續流

輔助人工心臟市場：依應用分類

• 通往心臟移植的橋樑
• DT治療
• 其他

輔助人工心臟市場：設計

• 市場概況：植入式輔助人工心臟
• 經皮心室輔助裝置

輔助人工心臟市場：依地區

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 阿拉伯聯合大公國國家
  • 南非
  • 其他中東、非洲

競爭資訊

• 前5名企業比較
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 依細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• FineHeart SA
• TELEFLEX INCORPORATED
• BiVACOR
• Abbott
• Berlin Heart
• Cardiac Assist, Inc.
• Jarvik Heart, Inc.
• ReliantHeart, Inc.
• SYNCARDIA SYSTEMS
• FRESENIUS MEDICAL CARE AG & CO. KGAA
• GETINGE
• SENKO MEDICAL INSTRUMENT MFG. CO., LTD
• ANGIODROID
• CARDIODYME
• WORLD HEART CORPORATION
• Sun Medical Technology Research Corporation
• CorWave SA
• Windmill Cardiovascular Systems
• Leviticus Cardio
• CardioBridge GmbH

結論和建議

Global Ventricular Assist Devices Market size was valued at USD 2.2 billion in 2022 and is poised to grow from USD 2.4 billion in 2023 to USD 5.9 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

The booming incidence of cardiovascular diseases, coupled with an escalating need for heart transplants, is set to significantly drive the sales of ventricular assist devices (VADs) in the coming years. The rapidly aging global population will further propel the demand for these life-saving devices. Innovations in the design and functionality of new VADs, alongside increased investments in research and development, are expected to unlock fresh opportunities for companies within this sector. Additionally, rising healthcare expenditures worldwide are likely to enhance revenue potential for VAD manufacturers. The growing acceptance and availability of total artificial hearts will also support market expansion throughout the forecast period and beyond. However, challenges such as the high cost of VADs, potential complications associated with their use, and a stringent regulatory landscape may temper the demand outlook in the long run. Overall, while the market presents robust growth prospects driven by demographic trends and technological advancements, stakeholders must navigate financial and regulatory hurdles to fully capitalize on these opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ventricular Assist Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ventricular Assist Devices Market Segmental Analysis

Global Ventricular Assist Devices Market is segmented by Product, Type of Flow, Design, Application, and region. Based on Product, the market is segmented into Left Ventricular Assist Device, Right Ventricular Assist Device, Bi-Ventricular Assist Device, Total Artificial Heart. Based on Type of Flow, the market is segmented into Pulsatile Flow, Continuous Flow. Based on Design, the market is Implantable Ventricular Assist Device, Transcutaneous Ventricular Assist Device. Based on Application, the market is segmented into Bridge to Transplant, Destination Therapy, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Ventricular Assist Devices Market

The Global Ventricular Assist Devices market is significantly driven by the growing acceptance and awareness surrounding these devices in recent years. As patients increasingly recognize the advantages that ventricular assist devices offer, their willingness to embrace these innovative solutions for heart support is rising. This shift in perception is anticipated to contribute to robust market growth, as more individuals consider these devices as viable options to enhance their treatment outcomes and overall quality of life. Consequently, the demand for ventricular assist devices is expected to continue its upward trajectory, fueled by both medical advancements and patient education.

Restraints in the Global Ventricular Assist Devices Market

The Global Ventricular Assist Devices market faces significant restraints primarily due to limited access in developing regions. These sophisticated medical devices are typically utilized in intricate procedures like heart transplants or the implementation of artificial hearts. However, many developing countries lack the infrastructure and resources to offer such advanced treatments, which restricts the market's potential for growth and sales in these areas. As a result, the inability to provide adequate healthcare options hinders the widespread adoption and distribution of ventricular assist devices, ultimately impacting the overall market dynamics and opportunities for manufacturers and healthcare providers.

Market Trends of the Global Ventricular Assist Devices Market

The global ventricular assist devices market is witnessing a significant trend towards miniaturization, driven by the need for improved implantation versatility and patient outcomes. Companies are increasingly adopting innovative design technologies and materials to create smaller, more efficient devices. This shift not only enhances usability in a broader range of patient anatomies but also aligns with the growing demand for less invasive surgical options. As market players focus on developing compact solutions, enhanced portability and minimized complications are expected to boost sales and market share, positioning these companies favorably in an increasingly competitive landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Supply Chain Analysis
• Pricing Analysis

Global Ventricular Assist Devices Market Size by Product & CAGR (2024-2031)

• Left Ventricular Assist Device
• Right Ventricular Assist Device
• Bi-Ventricular Assist Device
• Total Artificial Heart

Global Ventricular Assist Devices Market Size by Type of Flow & CAGR (2024-2031)

• Pulsatile Flow
• Continuous Flow

Global Ventricular Assist Devices Market Size by Application & CAGR (2024-2031)

• Bridge to Transplant
• Destination Therapy
• Others

Global Ventricular Assist Devices Market Size by Design & CAGR (2024-2031)

• Market Overview Implantable Ventricular Assist Device
• Transcutaneous Ventricular Assist Device

Global Ventricular Assist Devices Market Size & CAGR (2024-2031)

• North America, (Product, Type of Flow, Application, Design)
  • US
  • Canada
• Europe, (Product, Type of Flow, Application, Design)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Type of Flow, Application, Design)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Type of Flow, Application, Design)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Type of Flow, Application, Design)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• FineHeart SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TELEFLEX INCORPORATED
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVACOR
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Assist, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReliantHeart, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYNCARDIA SYSTEMS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FRESENIUS MEDICAL CARE AG & CO. KGAA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GETINGE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SENKO MEDICAL INSTRUMENT MFG. CO., LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANGIODROID
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARDIODYME
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WORLD HEART CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Medical Technology Research Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorWave SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Windmill Cardiovascular Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leviticus Cardio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioBridge GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation